首页> 外国专利> POXVIRUS HOST RANGE PROTEIN K3 AS A POSITIVE SELECTION MARKER FOR GENERATION OF RECOMBINANT POXVIRUSES, A THERAPEUTIC TARGET FOR POXVIRUS INFECTION AND A THERAPEUTIC AGENT FOR PKR RELATED DISEASES

POXVIRUS HOST RANGE PROTEIN K3 AS A POSITIVE SELECTION MARKER FOR GENERATION OF RECOMBINANT POXVIRUSES, A THERAPEUTIC TARGET FOR POXVIRUS INFECTION AND A THERAPEUTIC AGENT FOR PKR RELATED DISEASES

机译:POXVIRUS宿主蛋白K3作为产生重组POV病毒的阳性选择标记,POV病毒感染的治疗靶标和PKR相关疾病的治疗剂

摘要

Described herein is a novel method for generation of recombinant poxviruses using an E3 and K3 double deletion mutant virus as the parental virus for generation of recombinant viruses. Following allowing for crossing over between the parental virus and an insertion cassette including an orthopox K3 peptide and the gene of interest, recombinant viruses are selected by infecting a host cell line permissive for the orthopox K3 peptide but not for the E3 and K3 double mutant parental virus. It is also demonstrated that a specific small molecule inhibitor of NEDD8 activating enzyme, MLN4924, can completely block poxvirus K3 family protein mediated PKR degradation and virus replication.
机译:本文描述了使用E3和K3双重缺失突变体病毒作为亲本病毒来产生重组病毒的,用于产生重组痘病毒的新方法。在允许亲本病毒与包含正痘K3肽和目的基因的插入盒之间进行交换后,通过感染允许对正痘K3肽但对E3和K3双突变亲本不容许的宿主细胞系来选择重组病毒病毒。还证明了NEDD8活化酶的特定小分子抑制剂MLN4924可以完全阻断痘病毒K3家族蛋白介导的PKR降解和病毒复制。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号